Advertisement

Long-term Survivors of Childhood Brain Tumors: Impact on General Health and Quality of Life

  • Priyamvada Gupta
  • Rakesh JalaliEmail author
Neuro-Oncology (L. E. Abrey, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Neuro-Oncology

Abstract

Purpose of Review

We review and summarize the key issues affecting general health and quality of life (QOL) of pediatric long-term survivors of brain tumors.

Recent Findings

Long-term survivors of brain tumors are at risk of considerable late morbidity and mortality. Lengthening survival in brain tumors has highlighted the deep impact of tumor and its treatment on the physical, psychological, functional, and social health and QOL of these survivors. Evolution in tumor therapy including surgery, radiotherapy, and systemic therapies, etc., has the potential to mitigate this impact to some extent.

Summary

Sensitization of health staff, policy makers, and the primary designers of clinical trials towards integration of QOL end points while measuring survival in brain tumor patients is the need of the hour. New developments in tumor therapeutics must not only provide quantitative gain but also improve the quality of survival in these long-term survivors. While majority of the issues presented pertain to survivorship in pediatric brain tumor population, similar challenges are likely to exist in young adults surviving brain tumors as well.

Keywords

Brain tumors Long-term survivors Cancer survivors Childhood brain tumors 

Notes

Compliance with Ethical Standards

Conflict of Interest

Priyamvada Gupta and Rakesh Jalali each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki Declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Papathoma P, Thomopoulos TP, Karalexi MA, Ryzhov A, Zborovskaya A, Dimitrova N, et al. Childhood central nervous system tumours: incidence and time trends in 13 Southern and Eastern European cancer registries. Eur J Cancer. 2015;51(11):1444–55.PubMedCrossRefGoogle Scholar
  2. 2.
    Ullrich NJ, Embry L. Neurocognitive dysfunction in survivors of childhood brain tumors. Semin Pediatr Neurol. 2012;19(1):35–42.PubMedCrossRefGoogle Scholar
  3. 3.
    •• Armstrong GT, Chen Y, Yasui Y, Leisenring W, Gibson TM, Mertens AC, et al. Reduction in late mortality among 5-year survivors of childhood cancer. N Engl J Med. 2016;374(9):833–42. CCSS group studied late mortality in > 34,000 childhood cancer survivors including > 6,000 CNS patients, showing that 40% of deaths are due to health-related causes. Evolution in treatment over two decades directly reduced late mortality by lowering the therapeutic exposure. PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Labussière M, Boisselier B, Mokhtari K, Di Stefano A-L, Rahimian A, Rossetto M, et al. Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes. Neurology. 2014;83(13):1200–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Cairncross G, Wang M, Shaw E, Jenkins R, Brachman D, Buckner J, et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol. 2013;31(3):337–43.PubMedCrossRefGoogle Scholar
  6. 6.
    Bloom HJ, Wallace EN, Henk JM. The treatment and prognosis of medulloblastoma in children. A study of 82 verified cases. Am J Roentgenol Radium Therapy, Nucl Med. 1969;105(1):43–62.CrossRefGoogle Scholar
  7. 7.
    Mostow EN, Byrne J, Connelly RR, Mulvihill JJ. Quality of life in long-term survivors of CNS tumors of childhood and adolescence. J Clin Oncol. 1991;9(4):592–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Frange P, Alapetite C, Gaboriaud G, Bours D, Zucker JM, Zerah M, et al. From childhood to adulthood: long-term outcome of medulloblastoma patients. The Institut Curie experience (1980–2000). J Neuro-Oncol. 2009;95(2):271–9.CrossRefGoogle Scholar
  9. 9.
    Hudson MM, Mertens AC, Yasui Y, Hobbie W, Chen H, Gurney JG, et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA. 2003;290(12):1583–92.PubMedCrossRefGoogle Scholar
  10. 10.
    Robinson KE, Kuttesch JF, Champion JE, Andreotti CF, Hipp DW, Bettis A, et al. A quantitative meta-analysis of neurocognitive sequelae in survivors of pediatric brain tumors. Pediatr Blood Cancer. 2010;55(3):525–31.PubMedCrossRefGoogle Scholar
  11. 11.
    Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children’s Cancer Group Study. J Clin Oncol. 2001;19(15):3470–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Grill J, Renaux VK, Bulteau C, Viguier D, Levy-Piebois C, Sainte-Rose C, et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys. 1999;45(1):137–45.PubMedCrossRefGoogle Scholar
  13. 13.
    Ellenberg L, Liu Q, Gioia G, Yasui Y, Packer RJ, Mertens A, et al. Neurocognitive status in long-term survivors of childhood CNS malignancies: a report from the Childhood Cancer Survivor Study. Neuropsychology. 2009;23(6):705–17.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Duffner PK. Risk factors for cognitive decline in children treated for brain tumors. Eur J Paediatr Neurol. 2010;14(2):106–15.PubMedCrossRefGoogle Scholar
  15. 15.
    Butler RW, Fairclough DL, Katz ER, Kazak AE, Noll RB, Thompson RD, et al. Intellectual functioning and multi-dimensional attentional processes in long-term survivors of a central nervous system related pediatric malignancy. Life Sci. 2013;93(17):611–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Limond JA, Bull KS, Calaminus G, Kennedy CR, Spoudeas HA, Chevignard MP. Quality of survival assessment in European childhood brain tumour trials, for children aged 5 years and over. Eur J Paediatr Neurol. 2015;19(2):202–10.PubMedCrossRefGoogle Scholar
  17. 17.
    Chemaitilly W, Li Z, Huang S, Ness KK, Clark KL, Green DM, et al. Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort Study. J Clin Oncol. 2015;33(5):492–500.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Merchant TE, Goloubeva O, Pritchard DL, Gaber MW, Xiong X, Danish RK, et al. Radiation dose-volume effects on growth hormone secretion. Int J Radiat Oncol Biol Phys. 2002;52(5):1264–70.PubMedCrossRefGoogle Scholar
  19. 19.
    Merchant TE, Rose SR, Bosley C, Wu S, Xiong X, Lustig RH. Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors. J Clin Oncol. 2011;29(36):4776–80.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    • Gunn ME, Lähdesmäki T, Malila N, Arola M, Grönroos M, Matomäki J, et al. Late morbidity in long-term survivors of childhood brain tumors: a nationwide registry-based study in Finland. Neuro-Oncology. 2015;17(5):747–56. The authors showed that risk of development of endocrinopathies, cognitive deficits, developmental disorders, and neurological diseases at > 5 years from cancer diagnosis is many times higher in childhood BTLS as compared to that in siblings. PubMedCrossRefGoogle Scholar
  21. 21.
    Hua C, Bass JK, Khan R, Kun LE, Merchant TE. Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose. Int J Radiat Oncol Biol Phys. 2008;72(3):892–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Orgel E, Jain S, Ji L, Pollick L, Si S, Finlay J, et al. Hearing loss among survivors of childhood brain tumors treated with an irradiation-sparing approach. Pediatr Blood Cancer. 2012;58(6):953–8.PubMedCrossRefGoogle Scholar
  23. 23.
    • Brinkman TM, Bass JK, Li Z, Ness KK, Gajjar A, Pappo AS, et al. Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: results from the St. Jude Lifetime Cohort Study. Cancer. 2015;121(22):4053–61. Serious therapy-related hearing loss is seen in a third of childhood BTLS, with significant adverse impact on their education, employment, and independent living. PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–82.PubMedCrossRefGoogle Scholar
  25. 25.
    Bowers DC, Liu Y, Leisenring W, McNeil E, Stovall M, Gurney JG, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24(33):5277–82.PubMedCrossRefGoogle Scholar
  26. 26.
    • Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbüchel AMM, Müller HL. Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro-Oncology. 2015;17(7):1029–38. Hypothalamic involvement in craniopharyngioma may cause severe long-term obesity, reduced 20-year OS, and worse long-term QOL in survivors. PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Nolan VG, Gapstur R, Gross CR, Desain LA, Neglia JP, Gajjar A, et al. Sleep disturbances in adult survivors of childhood brain tumors. Qual Life Res. 2013;22(4):781–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Oeffinger KC, Mertens AC, Sklar CA, Yasui Y, Fears T, Stovall M, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2003;21(7):1359–65.PubMedCrossRefGoogle Scholar
  29. 29.
    Ross L, Johansen C, Dalton SO, Mellemkjaer L, Thomassen LH, Mortensen PB, et al. Psychiatric hospitalizations among survivors of cancer in childhood or adolescence. N Engl J Med. 2003;349(7):650–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Litofsky SN, Resnick AG. The relationships between depression and brain tumors. J Neuro-Oncol. 2009;94(2):153–61.CrossRefGoogle Scholar
  31. 31.
    Litofsky NS, Farace E, Anderson F, Meyers CA, Huang W, Laws ER, et al. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery. 2004;54(2):358–66-7.PubMedCrossRefGoogle Scholar
  32. 32.
    Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neuro-Oncol. 2002;57(1):41–9.CrossRefGoogle Scholar
  33. 33.
    Fox SW, Lyon D, Farace E. Symptom clusters in patients with high-grade glioma. J Nurs Scholarsh an Off Publ Sigma Theta Tau Int Honor Soc Nurs. 2007;39(1):61–7.Google Scholar
  34. 34.
    Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC. Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys. 2003;55(4):992–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Brown PD, Maurer MJ, Rummans TA, Pollock BE, Ballman KV, Sloan JA, et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery. 2005;57(3):495–504.PubMedCrossRefGoogle Scholar
  36. 36.
    • Brinkman TM, Liptak CC, Delaney BL, Chordas CA, Muriel AC, Manley PE. Suicide ideation in pediatric and adult survivors of childhood brain tumors. J Neuro-Oncol. 2013;113(3):425–32. Nearly 12% of BTLS reported suicide ideation, especially those with previous history of seizures or depression CrossRefGoogle Scholar
  37. 37.
    Rueegg CS, Michel G, Wengenroth L, von der Weid NX, Bergstraesser E, Kuehni CE, et al. Physical performance limitations in adolescent and adult survivors of childhood cancer and their siblings. PLoS One. 2012;7(10):e47944.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    •• Hobbie WL, Ogle S, Reilly M, Barakat L, Lucas MS, Ginsberg JP, et al. Adolescent and young adult survivors of childhood brain tumors: life after treatment in their own words. Cancer Nurs. 2017;39(2):134–43. The authors provide a unique perspective of life after brain tumor treatment in the survivors’ own words, highlighting the long-term impact of therapy-related morbidity. CrossRefGoogle Scholar
  39. 39.
    French AE, Tsangaris E, Barrera M, Guger S, Brown R, Urbach S, et al. School attendance in childhood cancer survivors and their siblings. J Pediatr. 2013;162(1):160–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Yağci-Küpeli B, Yalçin B, Küpeli S, Varan A, Akyüz C, Kutluk T, et al. Educational achievement, employment, smoking, marital, and insurance statuses in long-term survivors of childhood malignant solid tumors. J Pediatr Hematol Oncol. 2013;35(2):129–33.PubMedCrossRefGoogle Scholar
  41. 41.
    Lancashire ER, Frobisher C, Reulen RC, Winter DL, Glaser A, Hawkins MM. Educational attainment among adult survivors of childhood cancer in Great Britain: a population-based cohort study. J Natl Cancer Inst. 2010;102(4):254–70.PubMedCrossRefGoogle Scholar
  42. 42.
    Bonneau J, Lebreton J, Taque S, Chappe C, Bayart S, Edan C, et al. School performance of childhood cancer survivors: mind the teenagers! J Pediatr. 2011;158(1):135–41.PubMedCrossRefGoogle Scholar
  43. 43.
    Lorenzi M, McMillan AJ, Siegel LS, Zumbo BD, Glickman V, Spinelli JJ, et al. Educational outcomes among survivors of childhood cancer in British Columbia, Canada: report of the Childhood/Adolescent/Young Adult Cancer Survivors (CAYACS) Program. Cancer. 2009;115(10):2234–45.PubMedCrossRefGoogle Scholar
  44. 44.
    Gurney JG, Krull KR, Kadan-Lottick N, Nicholson HS, Nathan PC, Zebrack B, et al. Social outcomes in the childhood cancer survivor study cohort. J Clin Oncol. 2009;27(14):2390–5.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Green DM, Zevon MA, Hall B. Achievement of life goals by adult survivors of modern treatment for childhood cancer. Cancer. 1991;67(1):206–13.PubMedCrossRefGoogle Scholar
  46. 46.
    de Boer AGEM, Verbeek JHAM, van Dijk FJH. Adult survivors of childhood cancer and unemployment. Cancer 2006;107(1):1–11.Google Scholar
  47. 47.
    Armstrong GT, Liu Q, Yasui Y, Huang S, Ness KK, Leisenring W, et al. Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2009;101(13):946–58.PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Pang JWY, Friedman DL, Whitton JA, Stovall M, Mertens AC, Robison LL, et al. Employment status among adult survivors in the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2008;50(1):104–10.PubMedCrossRefGoogle Scholar
  49. 49.
    Koch SV, Kejs AMT, Engholm G, Møller H, Johansen C, Schmiegelow K. Leaving home after cancer in childhood: a measure of social independence in early adulthood. Pediatr Blood Cancer. 2006;47(1):61–70.PubMedCrossRefGoogle Scholar
  50. 50.
    Bhat SR, Goodwin TL, Burwinkle TM, Lansdale MF, Dahl GV, Huhn SL, et al. Profile of daily life in children with brain tumors: an assessment of health-related quality of life. J Clin Oncol. 2005;23(24):5493–500.PubMedCrossRefGoogle Scholar
  51. 51.
    • Chevignard M, Câmara-costa H, Doz F, Dellatolas G. Core deficits and quality of survival after childhood medulloblastoma: a review. Neuro-Oncology Pract. 2017;4(2):82–97. An insightful review of the long-term dysfunction and its causative factors in childhood medulloblastoma survivors Google Scholar
  52. 52.
    Fuemmeler BF, Elkin TD, Mullins LL. Survivors of childhood brain tumors: behavioral, emotional, and social adjustment. Clin Psychol Rev. 2002;22(4):547–85.PubMedCrossRefGoogle Scholar
  53. 53.
    Mattsson E, Lindgren B, Von Essen L. Are there any positive consequences of childhood cancer? A review of the literature. Acta Oncol (Madr). 2008;47(2):199–206.CrossRefGoogle Scholar
  54. 54.
    Stam H, Grootenhuis MA, Last BF. The course of life of survivors of childhood cancer. Psychooncology. 2005;14(3):227–38.PubMedCrossRefGoogle Scholar
  55. 55.
    van Dijk EM, van Dulmen-den Broeder E, Kaspers GJL, van Dam EWCM, Braam KI, Huisman J. Psychosexual functioning of childhood cancer survivors. Psychooncology 2008;17(5):506–511.Google Scholar
  56. 56.
    Koch SV, Mette A, Kejs T, Engholm G, Mller H, Johansen C, et al. Marriage and divorce among childhood cancer survivors. J Pediatr Hematol Oncol. 2011;33(7):500–5.PubMedCrossRefGoogle Scholar
  57. 57.
    Pivetta E, Maule MM, Pisani P, Zugna D, Haupt R, Jankovic M, et al. Marriage and parenthood among childhood cancer survivors: a report from the Italian AIEOP Off-Therapy Registry. Haematologica. 2011;96(5):744–51.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Janson C, Leisenring W, Cox C, Termuhlen AM, Mertens AC, Whitton JA, et al. Predictors of marriage and divorce in adult survivors of childhood cancers: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomark Prev. 2009;18(10):2626–35.CrossRefGoogle Scholar
  59. 59.
    Frobisher C, Lancashire ER, Winter DL, Taylor AJ, Reulen RC, Hawkins MM, et al. Long-term population-based divorce rates among adult survivors of childhood cancer in Britain. Pediatr Blood Cancer. 2010;54(1):116–22.PubMedCrossRefGoogle Scholar
  60. 60.
    Armstrong GT. Long-term survivors of childhood central nervous system malignancies: the experience of the Childhood Cancer Survivor Study. Eur J Paediatr Neurol. 2010;14(4):298–303.PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the childhood cancer survivor study. J Clin Oncol. 2009;27(14):2328–38.PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, et al. Long-term survival with glioblastoma multiforme. Brain. 2007;130(Pt 10):2596–606.PubMedCrossRefGoogle Scholar
  63. 63.
    Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010;102(14):1083–95.Google Scholar
  64. 64.
    •• Tallen G, Resch A, Calaminus G, Wiener A, Leiss U, Pletschko T, et al. Strategies to improve the quality of survival for childhood brain tumour survivors. Eur J Paediatr Neurol. 2015;19(6):619–39. The authors have studied the QOL issues in European childhood BTLS in detail and provided recommendations covering all the aspects of treatment to improve long-term QOL of survivors. PubMedCrossRefGoogle Scholar
  65. 65.
    Armstrong GT, Sklar CA, Hudson MM, Robison LL. Long-term health status among survivors of childhood cancer: does sex matter? J Clin Oncol. 2007;25(28):4477–89.PubMedCrossRefGoogle Scholar
  66. 66.
    Butler RW, Copeland DR, Fairclough DL, Mulhern RK, Katz ER, Kazak AE, et al. A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol. 2008;76(3):367–78.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Butler RW, Copeland DR. Attentional processes and their remediation in children treated for cancer: a literature review and the development of a therapeutic approach. J Int Neuropsychol Soc. 2002;8(1):115–24.PubMedCrossRefGoogle Scholar
  68. 68.
    Patel SK, Katz ER, Richardson R, Rimmer M, Kilian S. Cognitive and problem solving training in children with cancer: a pilot project. J Pediatr Hematol Oncol. 2009;31(9):670–7.PubMedCrossRefGoogle Scholar
  69. 69.
    Hardy KK, Willard VW, Bonner MJ. Computerized cognitive training in survivors of childhood cancer: a pilot study. J Pediatr Oncol Nurs. 2011;28(1):27–33.PubMedCrossRefGoogle Scholar
  70. 70.
    Thompson SJ, Leigh L, Christensen R, Xiong X, Kun LE, Heideman RL, et al. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol. 2001;19(6):1802–8.PubMedCrossRefGoogle Scholar
  71. 71.
    Conklin HM, Reddick WE, Ashford J, Ogg S, Howard SC, Morris EB, et al. Long-term efficacy of methylphenidate in enhancing attention regulation, social skills, and academic abilities of childhood cancer survivors. J Clin Oncol. 2010;28(29):4465–72.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Gehring K, Patwardhan SY, Collins R, Groves MD, Etzel CJ, Meyers CA, et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neuro-Oncol. 2012;107(1):165–74.CrossRefGoogle Scholar
  73. 73.
    Shaw EG, Rosdhal R, D’Agostino RB, Lovato J, Naughton MJ, Robbins ME, et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol. 2006;24(9):1415–20.PubMedCrossRefGoogle Scholar
  74. 74.
    Castellino SM, Tooze JA, Flowers L, Hill DF, McMullen KP, Shaw EG, et al. Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: a pilot study. Pediatr Blood Cancer. 2012;59(3):540–7.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Radcliffe J, Bennett DS, Kazan AE, Foley B, Phillip PC. Adjustment in childhood brain tumor survival: child, mother, and teacher report. J Pediatr Psychol. 1996;21(4):529–39.PubMedCrossRefGoogle Scholar
  76. 76.
    Carlson-Green B, Morris RD, Krawiecki N. Family and illness predictors of outcome in pediatric brain tumors. J Pediatr Psychol. 1995;20(6):769–84.PubMedCrossRefGoogle Scholar
  77. 77.
    Hocking MC, Hobbie WL, Deatrick JA, Hardie TL, Barakat LP. Family functioning mediates the association between neurocognitive functioning and health-related quality of life in young adult survivors of childhood brain tumors. J Adolesc Young Adult Oncol. 2015;4(1):18–25.PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Ness KK, Hudson MM, Ginsberg JP, Nagarajan R, Kaste SC, Marina N, et al. Physical performance limitations in the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27(14):2382–9.PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Peterson CC, Drotar D. Family impact of neurodevelopmental late effects in survivors of pediatric cancer: review of research, clinical evidence, and future directions. Clin Child Psychol Psychiatry. 2006;11(3):349–66.PubMedCrossRefGoogle Scholar
  80. 80.
    Hocking MC, Hobbie WL, Deatrick JA, Lucas MS, Szabo MM, Volpe EM, et al. Neurocognitive and family functioning and quality of life among young adult survivors of childhood brain tumors. Clin Neuropsychol. 2011;25(6):942–62.PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    Georgiadi M, Kourkoutas EE. Supporting pupils with cancer on their return to school: a case study report of a reintegration program. Procedia - Soc Behav Sci. 2010;5(2):1273–7.Google Scholar
  82. 82.
    Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 2004;5(7):399–408.PubMedCrossRefGoogle Scholar
  83. 83.
    Mariotto AB, Rowland JH, Yabroff KR, Scoppa S, Hachey M, Ries L, et al. Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomark Prev. 2009;18(4):1033–40.CrossRefGoogle Scholar
  84. 84.
    Kuhnt D, Ganslandt O, Schlaffer S-M, Buchfelder M, Nimsky C. Quantification of glioma removal by intraoperative high-field magnetic resonance imaging: an update. Neurosurgery. 2011;69(4):852–63.PubMedCrossRefGoogle Scholar
  85. 85.
    Ulrich NH, Burkhardt J-K, Serra C, Bernays R-L, Bozinov O. Resection of pediatric intracerebral tumors with the aid of intraoperative real-time 3-D ultrasound. Childs Nerv Syst. 2012;28(1):101–9.PubMedCrossRefGoogle Scholar
  86. 86.
    Ahmad F, Sandberg DI. Endoscopic management of intraventricular brain tumors in pediatric patients: a review of indications, techniques, and outcomes. J Child Neurol. 2010;25(3):359–67.PubMedCrossRefGoogle Scholar
  87. 87.
    • Jalali R, Gupta T, Goda JS, Goswami S, Shah N, Dutta D, et al. Efficacy of stereotactic conformal radiotherapy vs conventional radiotherapy on benign and low-grade brain tumors: a randomized clinical trial. JAMA Oncol. 2017;3(10):1368–76. Level 1 evidence has been generated with this RCT for benefit of modern high-precision conformal RT over conventional RT to preserve neurocognitive and endocrine functions in pediatric benign/low-grade CNS tumors. PubMedCrossRefGoogle Scholar
  88. 88.
    Doger de Speville E, Robert C, Perez-Guevara M, Grigis A, Bolle S, Pinaud C, et al. Relationships between regional radiation doses and cognitive decline in children treated with cranio-spinal irradiation for posterior fossa tumors. Front Oncol. 2017;7:166.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Moxon-Emre I, Bouffet E, Taylor MD, Laperriere N, Scantlebury N, Law N, et al. Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma. J Clin Oncol. 2014;32(17):1760–8.PubMedCrossRefGoogle Scholar
  90. 90.
    Carrie C, Grill J, Figarella-Branger D, Bernier V, Padovani L, Habrand JL, et al. Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98. J Clin Oncol. 2009;27(11):1879–83.PubMedCrossRefGoogle Scholar
  91. 91.
    Merchant TE, Hua C, Shukla H, Ying X, Nill S, Oelfke U. Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer. 2008;51(1):110–7.PubMedCrossRefGoogle Scholar
  92. 92.
    Yock TI, Bhat S, Szymonifka J, Yeap BY, Delahaye J, Donaldson SS, et al. Quality of life outcomes in proton and photon treated pediatric brain tumor survivors. Radiother Oncol. 2014;113(1):89–94.PubMedPubMedCentralCrossRefGoogle Scholar
  93. 93.
    • Gondi V, Yock TI, Mehta MP. Proton therapy for paediatric CNS tumours - improving treatment-related outcomes. Nat Rev Neurol. 2016;12(6):334–45. The authors have provided a balanced review of all the evidence of the use of proton therapy in childhood CNS tumors, its benefit in limiting toxicities justifying the high costs. PubMedCrossRefGoogle Scholar
  94. 94.
    Koga T, Shin M, Maruyama K, Kamada K, Ota T, Itoh D, et al. Integration of corticospinal tractography reduces motor complications after radiosurgery. Int J Radiat Oncol. 2012;83(1):129–33.CrossRefGoogle Scholar
  95. 95.
    Pantelis E, Papadakis N, Verigos K, Stathochristopoulou I, Antypas C, Lekas L, et al. Integration of functional MRI and white matter tractography in stereotactic radiosurgery clinical practice. Int J Radiat Oncol. 2010;78(1):257–67.CrossRefGoogle Scholar
  96. 96.
    Igaki H, Sakumi A, Mukasa A, Saito K, Kunimatsu A, Masutani Y, et al. Corticospinal tract-sparing intensity-modulated radiotherapy treatment planning. Reports Pract Oncol Radiother J Gt Cancer Cent Pozn Polish Soc Radiat Oncol. 2014;19(5):310–6.Google Scholar
  97. 97.
    • Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford SC, Doz F, et al. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathol. 2016;131(6):821–31. Molecular-based risk stratification in medulloblastoma is the foundation of therapy de-escalation and personalized treatment for these patients PubMedPubMedCentralCrossRefGoogle Scholar
  98. 98.
    Thompson EM, Hielscher T, Bouffet E, Remke M, Luu B, Gururangan S, et al. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. Lancet Oncol. 2016;17(4):484–95.PubMedPubMedCentralCrossRefGoogle Scholar
  99. 99.
    Moxon-Emre I, Taylor MD, Bouffet E, Hardy K, Campen CJ, Malkin D, et al. Intellectual outcome in molecular subgroups of medulloblastoma. J Clin Oncol. 2016;34(34):4161–70.PubMedCrossRefGoogle Scholar
  100. 100.
    Archer TC, Mahoney EL, Pomeroy SL. Medulloblastoma: molecular classification-based personal therapeutics. Neurotherapeutics. 2017;14(2):265–73.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Neuro Oncology GroupTata Memorial Centre, Tata Memorial HospitalMumbaiIndia

Personalised recommendations